Lazard Asset Management LLC Acquires 243,054 Shares of BlackRock Health Sciences Term Trust $BMEZ

Lazard Asset Management LLC grew its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 64.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 621,604 shares of the company’s stock after purchasing an additional 243,054 shares during the quarter. Lazard Asset Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $8,926,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Kestra Advisory Services LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 4th quarter worth approximately $26,000. SouthState Bank Corp bought a new position in BlackRock Health Sciences Term Trust during the first quarter valued at $29,000. PNC Financial Services Group Inc. purchased a new stake in BlackRock Health Sciences Term Trust in the 1st quarter worth about $35,000. Geneos Wealth Management Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust in the first quarter worth about $40,000. Finally, Allworth Financial LP lifted its stake in shares of BlackRock Health Sciences Term Trust by 24,584.6% during the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after buying an additional 3,196 shares in the last quarter.

BlackRock Health Sciences Term Trust Trading Down 0.0%

BlackRock Health Sciences Term Trust stock opened at $15.48 on Thursday. BlackRock Health Sciences Term Trust has a 1-year low of $13.67 and a 1-year high of $15.80. The firm has a 50 day simple moving average of $14.91 and a 200 day simple moving average of $14.73.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be issued a $0.11 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 8.5%. The ex-dividend date of this dividend is Tuesday, September 15th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.